Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Rivas Capital
AddedFeb 11, 2024
UpdatedJun 28, 2026
Rivas Capital

Rivas Capital

Operating

Rivas Capital LLC: A private investment firm specializing in long-term tech investments.

Location
Cambridge, MA, US
Founded
2011
Firm
Compare
Portfolio
Employees
Website

Rivas Capital LLC is a private investment firm specializing in long-term investments in breakthrough technology businesses. The firm primarily focuses on companies within the technology sector and serves clients in Massachusetts. Rivas Capital typically invests across various stages, including Seed, Series A, Series C, Series D, and Series F rounds, with a notable presence in early to mid-stage funding rounds.

Notable portfolio companies include Aircuity, Clarify Health Solutions, Gamalon, Inari Agriculture, Lumicell, Nextrna Therapeutics, ReviveMed, and Zipline. Rivas Capital's key partners bring extensive experience and a strong network to the table, enhancing their investment strategy. The firm's investment philosophy centers on fostering innovation and supporting transformative technology ventures. Additionally, Rivas Capital offers strategic guidance and operational support to help portfolio companies scale effectively.

Rivas Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments13
Current Portfolio Count9
Total Portfolio Exits0

Top Investment Stages

Series A4 (33.3%)
Seed3 (25.0%)
Series D2 (16.7%)
Series Unknown2 (16.7%)
Series C1 (8.3%)

Stage Mix

Series A 33%Seed 25%Series D 17%Series Unknown 17%Series C 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Inari Agriculture logo

Inari Agriculture

Clarify Health Solutions logo

Clarify Health Solutions

Nextrna Therapeutics logo

Nextrna Therapeutics

Regenacy Pharmaceuticals logo

Regenacy Pharmaceuticals

Gamalon logo

Gamalon

ReviveMed logo

ReviveMed

Zipline logo

Zipline

Aircuity logo

Aircuity

Lumicell logo

Lumicell

Rivas Capital - Similar Investment Firms

Riveria Investment Group logo

Riveria Investment Group

riveriagroup.com

R7 Partners Management logo

R7 Partners Management

Riverside Partners logo

Riverside Partners

Rock River Capital Partners logo

Rock River Capital Partners

Tech Pioneers Fund logo

Tech Pioneers Fund

Riverside Acceleration Capital logo

Riverside Acceleration Capital

riverside.ac

Fairhaven Capital Partners logo

Fairhaven Capital Partners

Jacket River logo

Jacket River

jacketriver.com

Four Rivers Group logo

Four Rivers Group

EIV Capital logo

EIV Capital

eivcapital.com

Mainspring Capital Partners logo

Mainspring Capital Partners

mainspringcap.com

Rain Capital logo

Rain Capital

raincap.vc

Capitan Investment Partners logo

Capitan Investment Partners

Rubicon Technology Partners logo

Rubicon Technology Partners

rubicontp.com

468 Capital logo

468 Capital

468cap.com

Rivas Capital - Classification

Also Known As
  • Macro Continental, Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified